Company news for the latest period, shared with you.
Helping users win the tough battle to ensure the stable supply of anti‑epidemic medicines.
2023-01-04
With the optimization and adjustment of COVID‑19 prevention and control policies, coupled with the high viral load and rapid replication of the Omicron variant, market demand for antipyretic and analgesic drugs has surged recently. To effectively alleviate the public’s difficulties in accessing and using medication, Shandong Xinhua Pharmaceutical Co., Ltd., the largest domestic integrated manufacturer of ibuprofen API and finished dosage forms, has fully shouldered its responsibilities as a state‑owned enterprise, ensuring that production capacity is maximized.
Jiutian High-Tech, a subsidiary of Jiangsu Fengkeda Technology Co., Ltd., promptly dispatched its most capable personnel to the front lines of Xinhua Pharmaceutical’s production operations, helping the company mount a decisive effort to ensure the stable supply of essential medicines.
▲ Project site
Alcohols, as organic solvents, play a crucial role in the manufacturing processes of chemical‑synthesized active pharmaceutical ingredients such as ibuprofen. Jiutian High‑Tech has provided Xinhua Pharmaceutical with a customized solvent recovery solution, primarily for the production and recovery of anhydrous ethanol. Although conventional azeotropic distillation and extractive distillation have been scaled up to achieve highly mechanized anhydrous ethanol production, these methods suffer from high energy consumption, and improper operation of entrainers or extractants can lead to environmental pollution. As a key piece of equipment in API manufacturing, Jiutian High‑Tech’s independently developed molecular sieve membrane dehydration unit—employing green separation technology—provides users with high‑purity solvents while helping them address challenges such as high energy use, high material consumption, and significant environmental impact.
▲ Solvent Recovery Unit
Amid the ongoing pandemic, Jiutian High-Tech has formulated a series of strategic plans and safeguard measures to ensure the orderly continuation of production:
I. Proactively deploy measures and identify operational challenges.
We have expanded our workforce, implemented shift work, and made every effort to maximize existing production capacity, while continuously optimizing and refining our manufacturing processes to further enhance both production efficiency and product quality.
II. Systematic Review and Formulation of Supply Assurance Measures
While ensuring the safety of its own workforce, the company is racing against time and operating at full capacity to swiftly ramp up to peak production levels, while proactively coordinating with suppliers to keep operations running without interruption.
III. Strengthen Organization and Enhance Production Management
A production scheduling meeting was held to review key customers, concentrate premium resources, and prioritize ensuring the product supply for pharmaceutical manufacturers producing anti‑epidemic drugs.
Recent Company Updates
Leave a Message Online
We will assign a dedicated representative to follow up with you and provide you with professional service.
Contact Us
tel:400-102-3850
Phone:152 5098 8105(Sales)
Phone:180 5101 8794(Brand)
Phone:150 5188 2705(Purchasing)
Phone:180 9421 8428(Human Resources)
Fax: 025-68717755
Postal code: 211800
Email:info@9t-tech.com
Email:hr@9t-tech.com
Website:http://www.9t-tech.com
Address: No. 6 Buyue Road, Pukou Economic Development Zone, Nanjing City
Quick Links
Scan to follow us
The data presented on this website are partly derived from the company’s internal statistics and customer feedback and are provided for reference only. For specific product performance and applicability, please refer to the contract and technical agreement signed by both parties.
Website Development:China Enterprise Dynamics NanjingSEO